Steven Waguespack is an Endocrinology/Metabolic physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 310 publications with 14,268 citations (h-index 61). By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Endocrinology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 770304009
Telephone
713-792-6161Provider last certified this registry record 27 Aug 2020.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20243 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20234 payments
- PFIZER INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
51%l-Thyroxine41.6%Levothyroxine Sodium81%Synthroid19%Part D≥45 patientsl-Triiodothyronine5.5%Liothyronine Sodium100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
22.3%Kinase inhibitor22.3%Tafinlar39%Mekinist23%Lenvima20%Pazopanib Hcl17%Part D<11 patientsMetabolism & gastrointestinal
14.5%Corticosteroid6.1%Prednisone100%Part D<11 patientsGLP-1 receptor agonist4.5%Ozempic100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
The Medicine Forum
2022 - Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape
The Journal of Clinical Endocrinology & Metabolism
2020 - Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
Journal for ImmunoTherapy of Cancer
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”